Merit Medical Systems (MMSI) Stock Forecast & Price Target

Compare

273 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MMSI Analyst Ratings

Strong Buy

8 Buy

1 Hold

0 Sell

Based on 9 analysts giving stock ratings to

Merit

Medical Systems

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MMSI Stock 12 Month Forecast

Average Price Target

$107.11

▲(14.54%Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Merit Medical Systems in the last 3 months. The average price target is $107.11 with a high forecast of $112.00 and a low forecast of $100.00. The average price target represents a 14.54% change from the last price of $93.51.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"75":"$75","94":"$94","113":"$113","84.5":"$84.5","103.5":"$103.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":112,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$112.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":107.11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$107.11</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$100.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[75,84.5,94,103.5,113],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,93.64,95.05230769230769,96.46461538461539,97.87692307692308,99.28923076923077,100.70153846153846,102.11384615384615,103.52615384615385,104.93846153846154,106.35076923076923,107.76307692307692,109.17538461538462,110.58769230769231,{"y":112,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,93.64,94.67615384615385,95.71230769230769,96.74846153846154,97.78461538461538,98.82076923076923,99.85692307692308,100.89307692307692,101.92923076923077,102.96538461538461,104.00153846153846,105.03769230769231,106.07384615384615,{"y":107.11,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,93.64,94.12923076923077,94.61846153846155,95.1076923076923,95.59692307692308,96.08615384615385,96.57538461538462,97.06461538461538,97.55384615384615,98.04307692307692,98.5323076923077,99.02153846153846,99.51076923076923,{"y":100,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":76.63,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.15,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.64,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.12,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.68,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.61,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":104.83,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.72,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.04,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.45,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.2,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.64,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$112.00

Average Price Target$107.11

Lowest Price Target$100.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$109

Buy

16.57%

Upside

Reiterated

05/22/25

Merit Medical Systems' overall stock score is driven by strong financial performance and strategic corporate events that support growth. The earnings call provided a positive outlook, albeit with some challenges from tariffs and EPS guidance reduction. The valuation appears stretched, and technical indicators suggest a cautious near-term view.

Jason BednarPiper Sandler

Piper Sandler

$110

Buy

17.63%

Upside

Reiterated

06/20/25

Merit Medical Systems (MMSI) Receives a Buy from Piper Sandler

Larry BiegelsenWells Fargo

Wells Fargo

$108

Buy

15.50%

Upside

Reiterated

05/28/25

Positive Outlook for Merit Medical Systems Amid Tariff Reductions and Resilient Growth

John Young CFACanaccord Genuity

Canaccord Genuity

$108→$112

Buy

19.77%

Upside

Reiterated

05/20/25

Merit Medical price target raised to $112 from $108 at CanaccordMerit Medical price target raised to $112 from $108 at Canaccord

Michael MatsonNeedham

Needham

$108

Buy

15.50%

Upside

Reiterated

05/20/25

Merit Medical's Strategic Acquisition of Biolife Delaware: A Long-Term Growth Catalyst

Jayson BedfordRaymond James

Raymond James

$116→$108

Buy

15.50%

Upside

Reiterated

04/25/25

Merit Medical price target lowered at Raymond James, weakness an opportunityMerit Medical price target lowered at Raymond James, weakness an opportunity

Robbie MarcusJ.P. Morgan

J.P. Morgan

$120→$105

Buy

12.29%

Upside

Reiterated

04/25/25

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY) and Merit Medical Systems (NASDAQ: MMSI)

David RescottRobert W. Baird

Robert W. Baird

$111→$110

Buy

17.63%

Upside

Reiterated

04/25/25

Merit Medical price target lowered to $110 from $111 at BairdMerit Medical price target lowered to $110 from $111 at Baird

Michael PetuskyBarrington

Barrington

$111→$103

Buy

10.15%

Upside

Reiterated

04/25/25

Analysts Offer Insights on Healthcare Companies: Andlauer Healthcare Group (Other OTC: ANDHF) and Merit Medical Systems (NASDAQ: MMSI)

Craig BijouBank of America Securities

Bank of America Securities

$118→$100

Hold

6.94%

Upside

Reiterated

04/25/25

Hold Rating for Merit Medical Systems Amid Tariff Challenges and Limited Upside Potential

Steven LichtmanOppenheimer

Oppenheimer

$120→$116

Buy

24.05%

Upside

Reiterated

02/26/25

Merit Medical Systems, Inc. (MMSI) PT Lowered to $116 at OppenheimerOppenheimer analyst Steven Lichtman lowered the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $116.00 (from $120.00) while maintaining a Outperform rating.

James SidotiSidoti

Sidoti

$122

Buy

30.47%

Upside

Reiterated

01/14/25

Sidoti Reaffirms Their Buy Rating on Merit Medical Systems (MMSI)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$109

Buy

16.57%

Upside

Reiterated

05/22/25

Jason BednarPiper Sandler

Piper Sandler

$110

Buy

17.63%

Upside

Reiterated

06/20/25

Merit Medical Systems (MMSI) Receives a Buy from Piper Sandler

Larry BiegelsenWells Fargo

Wells Fargo

$108

Buy

15.50%

Upside

Reiterated

05/28/25

Positive Outlook for Merit Medical Systems Amid Tariff Reductions and Resilient Growth

John Young CFACanaccord Genuity

Canaccord Genuity

$108→$112

Buy

19.77%

Upside

Reiterated

05/20/25

Merit Medical price target raised to $112 from $108 at CanaccordMerit Medical price target raised to $112 from $108 at Canaccord

Michael MatsonNeedham

Needham

$108

Buy

15.50%

Upside

Reiterated

05/20/25

Merit Medical's Strategic Acquisition of Biolife Delaware: A Long-Term Growth Catalyst

Jayson BedfordRaymond James

Raymond James

$116→$108

Buy

15.50%

Upside

Reiterated

04/25/25

Merit Medical price target lowered at Raymond James, weakness an opportunityMerit Medical price target lowered at Raymond James, weakness an opportunity

Robbie MarcusJ.P. Morgan

J.P. Morgan

$120→$105

Buy

12.29%

Upside

Reiterated

04/25/25

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY) and Merit Medical Systems (NASDAQ: MMSI)

David RescottRobert W. Baird

Robert W. Baird

$111→$110

Buy

17.63%

Upside

Reiterated

04/25/25

Merit Medical price target lowered to $110 from $111 at BairdMerit Medical price target lowered to $110 from $111 at Baird

Michael PetuskyBarrington

Barrington

$111→$103

Buy

10.15%

Upside

Reiterated

04/25/25

Analysts Offer Insights on Healthcare Companies: Andlauer Healthcare Group (Other OTC: ANDHF) and Merit Medical Systems (NASDAQ: MMSI)

Craig BijouBank of America Securities

Bank of America Securities

$118→$100

Hold

6.94%

Upside

Reiterated

04/25/25

Hold Rating for Merit Medical Systems Amid Tariff Challenges and Limited Upside Potential

Steven LichtmanOppenheimer

Oppenheimer

$120→$116

Buy

24.05%

Upside

Reiterated

02/26/25

James SidotiSidoti

Sidoti

$122

Buy

30.47%

Upside

Reiterated

01/14/25

Sidoti Reaffirms Their Buy Rating on Merit Medical Systems (MMSI)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Merit Medical Systems

1 Month

xxx

Success Rate

23/31 ratings generated profit

Average Return

+4.91%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 74.19% of your transactions generating a profit, with an average return of +4.91% per trade.

3 Months

xxx

Success Rate

26/31 ratings generated profit

Average Return

+11.05%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 83.87% of your transactions generating a profit, with an average return of +11.05% per trade.

1 Year

Jayson BedfordRaymond James

Success Rate

21/31 ratings generated profit

Average Return

+23.65%

reiterated a buy rating 2 months ago

Copying Jayson Bedford's trades and holding each position for 1 Year would result in 67.74% of your transactions generating a profit, with an average return of +23.65% per trade.

2 Years

xxx

Success Rate

18/24 ratings generated profit

Average Return

+16.53%

reiterated a xxx

rating 15 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +16.53% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MMSI Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MMSI has received 18 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MMSI average Analyst price target in the past 3 months is 107.11.

Each month's total comprises the sum of three months' worth of ratings.

MMSI Financial Forecast

MMSI Earnings Forecast

Next quarter’s earnings estimate for MMSI is $0.85 with a range of $0.83 to $0.88. The previous quarter’s EPS was $0.86. MMSI beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year MMSI has Preformed in-line its overall industry.

MMSI Sales Forecast

Next quarter’s sales forecast for MMSI is $372.47M with a range of $369.60M to $374.97M. The previous quarter’s sales results were $354.33M. MMSI beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year MMSI has Preformed in-line its overall industry.

MMSI Stock Forecast FAQ

What is MMSI’s average 12-month price target, according to analysts?

Based on analyst ratings, Merit Medical Systems’s 12-month average price target is 107.11.

What is MMSI’s upside potential, based on the analysts’ average price target?

Merit Medical Systems has 14.54% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MMSI a Buy, Sell or Hold?

Merit Medical Systems has a consensus rating of Strong Buy which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.

What is Merit Medical Systems’s price target?

The average price target for Merit Medical Systems is 107.11. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $112.00 ,the lowest forecast is $100.00. The average price target represents 14.54% Increase from the current price of $93.51.

What do analysts say about Merit Medical Systems?

Merit Medical Systems’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of MMSI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Merit Medical Systems (MMSI) Stock Forecast & Price Target

MMSI Analyst Ratings

MMSI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Merit Medical Systems

MMSI Analyst Recommendation Trends

MMSI Financial Forecast

MMSI Earnings Forecast

MMSI Sales Forecast

MMSI Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts